Live feed17:21:00·597dPRReleasevia QuantisnowCUMBERLAND PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG AND RARE PEDIATRIC DISEASE DESIGNATIONS FOR NEW TREATMENT OF DUCHENNE MUSCULAR DYSTROPHYByQuantisnow·Wall Street's wire, on your screen.CPIX· Cumberland Pharmaceuticals Inc.Health Care
